Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)
- Conditions
- Lung Cancer
- Interventions
- Behavioral: Active pain management
- Registration Number
- NCT01310387
- Lead Sponsor
- Chonnam National University Hospital
- Brief Summary
This study is:
* A single-center, randomized, prospective controlled trial.
* To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.
* 204 patients will be recruited.
- Detailed Description
* The recruited patients in both group will be provided the education about pain-killer, and received medicines including opioids according to their numeric rating scale (NRS)
* Active management group will be provided additional telephone counseling and dosage modification by specialized nurse for cancer pain.
* The percent of pain intensity difference (%PID)
* PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
- Outpatients with lung cancer.
- The patients with uncontrolled lung cancer pain - more than and equal NRS 4 pain during previous 24 hours for background pain, or more than and equal 3 times/day for breakthrough painkiller medication.
- Over 20 year-old male or female.
- The patients can be able to received telephone counseling by investigator's decision.
- Drug or alcohol abusers.
- Child-bearing women or pregnant women.
- The patients with moderate to severe psychiatric problems.
- The patients who have hypersensitivity to opioids.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description active pain management Active pain management active pain management (APM) by specialized nurses for cancer pain
- Primary Outcome Measures
Name Time Method The percent of pain intensity difference visit 3 (6 to 8 weeks) The percent of pain intensity difference (%PID)
%PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1
- Secondary Outcome Measures
Name Time Method Patients' satisfaction score about pain management visit 3 (6 to 8 weeks) Qustionnaire of 5-point scale
Eastern Cooperative Oncology Group (ECOG) Performance score visit 3 (6 to 8 weeks) ECOG performance status: 0,1,2,3,4
Assessment of Korean Brief Pain Inventory score visit 3 (6 to 8 weeks) Qustionnaire; K-BPI(Korean Brief Pain Inventory)
Investigator's global assessment score visit 3 (6 to 8 weeks) Qustionnaire of 5-point scale
Trial Locations
- Locations (1)
Chonnam National University Hwasun Hospital
🇰🇷Jeonnam, Korea, Republic of